(Circulation. 1997;95:245-251.)
© 1997 American Heart Association, Inc.
Articles |
Beneficial Effects of Amlodipine in a Murine Model of Congestive Heart Failure Induced by Viral Myocarditis
A Possible Mechanism Through Inhibition of Nitric Oxide Production
the Departments of Cardiovascular Medicine (W.Z.W., A.M., T.Y., T.S., I.O., S.M., Y.S., H.S., S.S.) and Anatomy and Development Biology (W.Z.W., K.S.), Kyoto University, Kyoto, Japan.
Correspondence to Akira Matsumori, MD, The 3rd Division, Department of Internal Medicine, Faculty of Medicine, Kyoto University, 54 Kawaracho, Shogoin, Sakyo-ku, Kyoto, 606 Japan.
Background Although calcium channel blockers have not been shown to be beneficial for the treatment of patients with heart failure, a recent clinical trial demonstrated a favorable effect of amlodipine on the survival of patients with heart failure resulting from nonischemic dilated cardiomyopathy. We investigated the effects of amlodipine on a murine model of congestive heart failure induced by the M variant of encephalomyocarditis virus (EMCV).
Methods and Results Four-week-old male DBA/2 mice were inoculated with EMCV and administered amlodipine, diltiazem, or vehicle PO for 2 weeks. The heart weight–to–body weight ratio and the histopathological grades of myocardial lesions were significantly lower and survival was significantly increased in the amlodipine-treated group (P<.01, P<.05, and P<.05, respectively) than in the control group. In vitro, amlodipine added to murine J774A.1 macrophages concomitant with EMCV inhibited nitrite formation in a concentration-dependent manner, but diltiazem did not. Furthermore, NG-monomethyl-L-arginine, an inhibitor of NO synthesis, decreased myocardial lesions significantly in this murine model. Immunohistochemistry revealed that the number of cells stained with antibody against an inducible NO synthase decreased significantly in the amlodipine-treated group compared with that in the control group (P<.01).
Conclusions Amlodipine appears to have a protective effect against myocardial injury in this animal model of congestive heart failure. The therapeutic effect of amlodipine may be in part resulting from inhibition of overproduction of NO.
Key Words: myocarditis • heart failure • endothelium-derived factors
This article has been cited by other articles:
 |
|
 |
|
  A. Matsumori, Y. Nunokawa, A. Yamaki, K. Yamamoto, M.-W. Hwang, T. Miyamoto, M. Hara, R. Nishio, K. Kitaura-Inenaga, and K. Ono Suppression of cytokines and nitric oxide production, and protection against lethal endotoxemia and viral myocarditis by a new NF-{kappa}B inhibitor Eur J Heart Fail, March 1, 2004; 6(2): 137 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Nishio, S. Sasayama, and A. Matsumori Left ventricular pressure-volume relationship in a murine model of congestive heart failure due to acute viral myocarditis J. Am. Coll. Cardiol., October 16, 2002; 40(8): 1506 - 1514. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. I. Jugdutt and V. Menon Beneficial Effects of Therapy on the Progression of Structural Remodeling During Healing After Reperfused and Nonreperfused Myocardial Infarction: Different Effects on Different Parameters Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2002; 7(2): 95 - 107. [Abstract] [PDF]
|
|
|
|
|
|
Y. Ishibashi, T. Shimada, Y. Murakami, N. Takahashi, T. Sakane, T. Sugamori, S. Ohata, S.-i. Inoue, Y. Ohta, K. Nakamura, et al. An inhibitor of inducible nitric oxide synthase decreases forearm blood flow in patients with congestive heart failure J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1470 - 1476. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Feldman and D. McNamara Myocarditis N. Engl. J. Med., November 9, 2000; 343(19): 1388 - 1398. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Nishio, A. Matsumori, T. Shioi, H. Ishida, and S. Sasayama Treatment of Experimental Viral Myocarditis With Interleukin-10 Circulation, September 7, 1999; 100(10): 1102 - 1108. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Guillemard, B. Varano, F. Belardelli, A. M. Quero, and S. Gessani Inhibitory Activity of Constitutive Nitric Oxide on the Expression of Alpha/Beta Interferon Genes in Murine Peritoneal Macrophages J. Virol., September 1, 1999; 73(9): 7328 - 7333. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Sasayama, A. Matsumori, and Y. Kihara New insights into the pathophysiological role for cytokines in heart failure Cardiovasc Res, June 1, 1999; 42(3): 557 - 564. [Full Text] [PDF]
|
|
|
|
|
|
A. Iwasaki, A. Matsumori, T. Yamada, T. Shioi, W. Wang, K. Ono, R. Nishio, M. Okada, and S. Sasayama Pimobendan inhibits the production of proinflammatory cytokines and gene expression of inducible nitric oxide synthase in a murine model of viral myocarditis J. Am. Coll. Cardiol., April 1, 1999; 33(5): 1400 - 1407. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kumamoto, H. Okamoto, M. Watanabe, H. Onozuka, K. Yoneya, I. Nakagawa, S. Chiba, S. Watanabe, T. Mikami, K. Abe, et al. Beneficial effect of myocardial angiogenesis on cardiac remodeling process by amlodipine and MCI-154 Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1117 - H1123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Schwarz, C. Badorff, T. S. Hiura, R. Wessely, A. Badorff, I. M. Verma, and K. U. Knowlton NF-kappa B-Mediated Inhibition of Apoptosis Is Required for Encephalomyocarditis Virus Virulence: a Mechanism of Resistance in p50 Knockout Mice J. Virol., July 1, 1998; 72(7): 5654 - 5660. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. Paulus, S. Kastner, P. Pujadas, A. M. Shah, H. Drexler, and M. Vanderheyden Left Ventricular Contractile Effects of Inducible Nitric Oxide Synthase in the Human Allograft Circulation, November 18, 1997; 96(10): 3436 - 3442. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Mikami, S. Kawashima, K. Kanazawa, K.-i. Hirata, H. Hotta, Y. Hayashi, H. Itoh, and M. Yokoyama Low-Dose N{omega}-Nitro-L-Arginine Methyl Ester Treatment Improves Survival Rate and Decreases Myocardial Injury in a Murine Model of Viral Myocarditis Induced by Coxsackievirus B3 Circ. Res., October 19, 1997; 81(4): 504 - 511. [Abstract] [Full Text]
|
|